Background on Andrea del Bosque and Pfizer
Andrea del Bosque, the head of vaccines at Pfizer, is a key figure in Mexico’s ongoing Covid-19 vaccination efforts. Her expertise and insights are crucial for understanding the current state of the pandemic and vaccination campaigns in Mexico.
Current Situation of Covid-19 in Mexico
Although the number of Covid-19 cases has significantly decreased compared to 2024, the virus continues to circulate in Mexico. As winter approaches, the demand for vaccines remains high, according to del Bosque.
- As of December 18, there were 7,194 cases and 272 deaths due to the LP 8.1 variant.
- This represents a 49.1% decrease in cases and a 63% reduction in deaths compared to 2024, when there were 14,148 cases and 741 fatalities.
Despite the decline, del Bosque emphasized that lower temperatures, increased mobility, and indoor gatherings contribute to the virus’s transmission during this season.
Vulnerable Populations and Vaccination
Del Bosque highlighted the importance of vaccination, especially among vulnerable groups, to prevent complications.
- Vulnerable populations include pregnant women and individuals with chronic conditions such as obesity, diabetes, hypertension, heart or respiratory issues, and weakened immune systems (e.g., cancer patients).
- Vaccines are available in both the private and public sectors for different age groups, with specific presentations for children aged 6 months to 4 years, 5 to 11 years old, and individuals 12 years and older.
Vaccine Updates and International Recommendations
Del Bosque explained that the Covid-19 vaccine is updated annually to protect against the currently circulating variant.
- International organizations like the World Health Organization (WHO), the U.S. Food and Drug Administration (FDA), and the European Medicines Agency (EMA) identify the most relevant circulating variant.
- This year, the predominant variant is LP 8.1, and Pfizer’s vaccine has been updated accordingly.
In addition to vaccination, del Bosque recommended reinforcing preventive measures such as maintaining good physical condition and managing chronic diseases.
- Non-pharmacological preventive measures include ensuring proper ventilation, wearing masks (especially in enclosed spaces), and frequently washing hands.
Key Questions and Answers
- Q: Why is vaccination still important despite decreased cases? A: Vaccination remains crucial to prevent severe illness and complications, especially among vulnerable populations.
- Q: Who are the most vulnerable groups for Covid-19 complications? A: Pregnant women, individuals with chronic conditions (obesity, diabetes, hypertension, heart or respiratory issues), and those with weakened immune systems (e.g., cancer patients) are at higher risk.
- Q: How is the Covid-19 vaccine updated? A: The vaccine is updated annually based on the most relevant circulating variant identified by international organizations like the WHO, FDA, and EMA.
- Q: What additional preventive measures are recommended besides vaccination? A: Maintaining good physical condition, managing chronic diseases, ensuring proper ventilation, wearing masks in enclosed spaces, and frequently washing hands are essential preventive measures.
